Methylergometrine maleate
Methylergometrine maleate structure
|
Common Name | Methylergometrine maleate | ||
|---|---|---|---|---|
| CAS Number | 57432-61-8 | Molecular Weight | 455.50400 | |
| Density | 1.2744 (rough estimate) | Boiling Point | 638.4ºC at 760mmHg | |
| Molecular Formula | C24H29N3O6 | Melting Point | 172ºC (dec) | |
| MSDS | N/A | Flash Point | N/A | |
| Symbol |
GHS06, GHS08 |
Signal Word | Danger | |
|
Methylergometrine: adverse effects in breastfed infants.
Prescrire Int. 23(148) , 102, (2014)
|
|
|
[Reflections of an expert committee of the French Society of Cardiology on the use of methylergometrine maleate (Methergin) for the detection of abnormal coronary vasomotricity].
Arch. Mal. Coeur Vaiss. 88(2) , 247-53, (1995)
|
|
|
Oral methylergonovine maleate for refractory migraine and cluster headache prevention.
Headache 53(2) , 378-81, (2013)
|
|
|
Methylergonovine maleate as a cluster headache prophylactic: a study and review.
Headache 37(7) , 437-42, (1997) Methylergonovine maleate (Methergine), an ergot derivative with vasoconstrictive properties, has been cited as an effective treatment for vascular headaches. Few studies are available to support its use in headache management. An uncontrolled pilot study of 2... |
|
|
Risk factors for obstetric morbidity in patients with uterine atony undergoing caesarean delivery.
Br. J. Anaesth. 113(4) , 661-8, (2014) Uterine atony (UA) is recognized as a leading cause of postpartum haemorrhage. However, knowledge of risk factors of haemorrhage-related morbidity among patients diagnosed with UA is uncertain. We investigated risk factors for haemorrhage-related morbidity am... |